Mitochondria-driven ferroptosis in intervertebral disc degeneration: A novel target in age-related spinal diseases...

Area of Science:

• Biochemistry
• Cell Biology
• Regenerative Medicine

Background:

• Ferroptosis, an iron-dependent cell death, is implicated in intervertebral disc degeneration (IDD).
• Mitochondria play a critical role in ferroptosis by regulating iron metabolism, reactive oxygen species (ROS), and energy production.
• Mitochondrial dysfunction in IDD exacerbates lipid ROS accumulation and impairs antioxidant defenses, leading to cell death and matrix degradation.

Purpose of the Study:

• To review the molecular mechanisms of ferroptosis in IDD.
• To highlight the role of mitochondrial pathways in ferroptosis-mediated IDD.
• To discuss mitochondria-targeted therapeutic strategies for IDD.

Main Methods:

• Literature review of ferroptosis and mitochondrial mechanisms in IDD.
• Analysis of current therapeutic interventions targeting mitochondria.
• Synthesis of findings on ferroptosis, mitochondria, and IDD.

Main Results:

• Ferroptosis, driven by lipid peroxidation and ROS, is a key factor in IDD progression.
• Mitochondrial dysfunction contributes to ferroptosis by increasing ROS and decreasing GPX4 activity.
• Mitochondria-targeted therapies, including antioxidants and iron chelators, show promise for IDD treatment.

Conclusions:

• Mitochondrial dysfunction and ferroptosis are central to IDD pathogenesis.
• Targeting mitochondrial pathways offers a promising therapeutic avenue for IDD.
• Further research into mitochondria-ferroptosis interplay can yield novel IDD treatments.